Wednesday, September 21st 2022 - Friday, September 23rd 2022
Louvain-la-Neuve, 1348 Ottignies-Louvain-la-Neuve, België
€450.00 for non-members
€360.00 for members
€240.00 for Academia
€120.00 for PhD students
Nantes Université, UCLouvain, Atlanpole Biotherapies, BioWin, flanders.bio
Bioregate Forum is a biennial European meeting dedicated to the “4R Medicine”: Repair, Replacement, Regeneration & Reprogramming. A regenerative medicine forum to highlight latest scientific, technological, clinical & commercialization approaches in the field of cell & gene therapy, stem cells, biomaterials and tissue engineering. Its vocation is to enhance links between researchers, clinicians, industrials and institutional stakeholders such as those responsible for regulation and reimbursement changes, and thus to shorten time to market for the patients’ benefits.
For the first time, Bioregate Forum will take place outside of France. More information follows, so stay tuned!
CALL FOR ABSTRACT
This call is opened for short talks and posters.
Short talks and posters: experts from academia and industry can present their scientific work in all areas of regenerative medicine.
Pitches: only open to PhD Students.
Final selection will be made by the Scientific Advisory Committee.
Call for abstract schedule :
Abstract submission Opening: March 15th, 2022
Abstracts Submission Deadline: June 30th, 2022
Notification of Accepted Abstracts: July 15th, 2022
NB: Attendees accepted abstracts will be fully validated after registration and payment.
Applications now being accepted for late-breaking poster session (deadline July 20th)
Abstracts Submission Instructions :
Abstract template is required for submission
Preferred type of presentation (short talk or poster) should be indicated
Preferred session should be indicated
Abstract Format: The abstract length is limited to 2500 characters, with no figures or tables. References may be included.
Disclosures: Any relevant information should be indicated.
Abstracts have to be sent to email@example.com before June 30th, 2022.
For more information, click here.